Skip to main content
IMS Events Main banner

  1. Home

  • Wednesday, Sep 17th
    10:05 - 10:15 East Coast USA Time
    (NSO-02) Improving Capacity in the Malignant Hematology Day Unit by Increasing Subcutaneous Immunoglobulin Replacement Treatment in the Community
    Location: Room 501
    Abstract Presenter: Dior Caruso, MN-NP Adult, CHPCN(C) – Princess Margaret Cancer Centre
    Imaging, QoL and Patient-Reported Outcome and Supportive Care
  • Wednesday, Sep 17th
    10:15 - 10:25 East Coast USA Time
    (NSO-04) Patient Perspectives of Receiving Out-patient Step-up Dosing with Bispecific Antibodies (BsAb) for Relapsed Multiple Myeloma (MM)
    Location: Room 501
    Abstract Presenter: Jennifer Russell, MSc, BSc (Hons) – University College London Hospital
    Imaging, QoL and Patient-Reported Outcome and Supportive Care
  • Wednesday, Sep 17th
    11:15 - 11:25 East Coast USA Time
    (NSO-05) Patient Perceptions of Frailty and its Assessment in those Living with Myeloma
    Location: Room 501
    Imaging, QoL and Patient-Reported Outcome and Supportive Care
  • Wednesday, Sep 17th
    11:35 - 11:45 East Coast USA Time
    (NSO-03) Reframing Myeloma Supportive Care: Nurse-led Leadership to Improve Patient Outcomes
    Location: Room 501
    Abstract Presenter: Daniela Klarica, NP – Alfred Health
    Imaging, QoL and Patient-Reported Outcome and Supportive Care
  • Wednesday, Sep 17th
    12:44 - 12:50 East Coast USA Time
    (PA-529) Risk of Infections after Bispecific Antibodies Targeting Anti-B-cell Maturation Antigen (BCMA) in Multiple Myeloma-intravenous Immunoglobulin (IVIG) Significantly Lowers the Risk of Infection
    Location: Room 714A
    Abstract Presenter: Amandeep Godara, MD – University of Utah
    Imaging, QoL and Patient-Reported Outcome and Supportive Care
  • Wednesday, Sep 17th
    16:30 - 16:40 East Coast USA Time
    (OA-17) MRI Response According to MY-RADS Correlates with MRD Negativity After Induction in Newly Diagnosed Multiple Myeloma: Results from the GMMG-HD7 Trial
    Location: Room 701
    Abstract Presenter: Marina Hajiyianni, MD – Heidelberg Myeloma Center, Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
    Imaging, QoL and Patient-Reported Outcome and Supportive Care
  • Wednesday, Sep 17th
    16:40 - 16:50 East Coast USA Time
    (OA-18) The Value of Progression-Free Survival (PFS) from the Perspectives of Patients with Multiple Myeloma (MM) and Treating Physicians: Quantitative Research Findings from Eight Countries
    Location: Room 701
    Abstract Presenter: Aaron S. Rosenberg, MD, MS – UC Davis Comprehensive Cancer Center
    Imaging, QoL and Patient-Reported Outcome and Supportive Care
  • Wednesday, Sep 17th
    16:50 - 17:00 East Coast USA Time
    (OA-19) Prospective Evaluation of Response Assessment in Newly-Diagnosed Multiple Myeloma with Combined use of 18F-FDG-PET/CT, Whole-Body Diffusion-Weighted MRI and MRD by Next-Generation Sequencing
    Location: Room 701
    Abstract Presenter: Marco Talarico, marco.talarico – Università di Bologna - IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli"
    Imaging, QoL and Patient-Reported Outcome and Supportive Care
  • Wednesday, Sep 17th
    17:00 - 17:10 East Coast USA Time
    (OA-21) Dynamic Frailty Analysis of Transplant-Ineligible (TIE) Patients with NDMM in the Phase 3 MAIA and CEPHEUS Trials of Daratumumab (Dara) + Lenalidomide-Dexamethasone (Rd) and Bortezomib-Rd (VRd)
    Location: Room 701
    Abstract Presenter: Hira Mian, MD (she/her/hers) – McMaster University, Hamilton, ON, Canada
    Imaging, QoL and Patient-Reported Outcome and Supportive Care
  • Wednesday, Sep 17th
    17:10 - 17:20 East Coast USA Time
    (OA-20) Temporal Trends in Infectious Risk Among Multiple Myeloma Patients Treated with Daratumumab: A Meta-Analysis
    Location: Room 701
    Abstract Presenter: Alissa Visram, MD, MPH – Juravinski Cancer Centre / Hamilton Health Sciences
    Imaging, QoL and Patient-Reported Outcome and Supportive Care
  • Thursday, Sep 18th
    12:38 - 12:44 East Coast USA Time
    (PA-145) Treatment-Free Hospitalization-Free Time With CAR T-Cell Therapy Versus Standard Regimens and Quality of Life Implications in Patients With Relapsed/Refractory MM: Findings From the KarMMa-3 Trial
    Location: Room 714A
    Abstract Presenter: Krina K. Patel, MD, MSc (she/her/hers) – Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center
    Imaging, QoL and Patient-Reported Outcome and Supportive Care
  • Friday, Sep 19th
    12:59 - 13:05 East Coast USA Time
    (PA-144) Whole Body Magnetic Resonance Imaging (WBMRI) for Response Evaluation in Patients with Multiple Myeloma
    Location: Room 714A
    Abstract Presenter: Ioannis Ntanasis-Stathopoulos, MD (he/him/his) – Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
    Imaging, QoL and Patient-Reported Outcome and Supportive Care